Status:
UNKNOWN
Reading Performance in Patients With Acrysof IQ Vivity Versus Acrysof IQ
Lead Sponsor:
Vienna Institute for Research in Ocular Surgery
Conditions:
Cataract
Eligibility:
All Genders
21-105 years
Phase:
NA
Brief Summary
Comparison of the visual function and reading performance between the Acrysof IQ Vivity IOL, an EDOF IOL, and the monofocal Acrysof IQ.
Detailed Description
With increasing demands of patients concerning their visual function after cataract surgery, a variety of advanced technology intraocular lenses (IOL) have become available in the last years. Various ...
Eligibility Criteria
Inclusion
- Cataract
- Stereopsis
- age 21 and older
- regular corneal astigmatism of up to 3.0 D
- written informed consent prior to surgery
- normal findings in the medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant
- availability, willingness and sufficient cognitive awareness to comply with examination procedures
- german as mother-tongue
- calculated IOL power needed is below 15.0 D or above 25.0 D (no high myopia or high hypermetropia will be recruited)
Exclusion
- relevant other ophthalmic diseases such as: pseudoexfoliation, glaucoma, traumatic cataract, corneal scars, and other co-morbidity that could affect capsule bag stability (e.g. Marfan syndrome) or retinal diseases affecting visual acuity (AMD, Macular Pucker, post-operative macular edema...)
- amblyopia
- contact lenses
- irregular corneal astigmatism on corneal topography
- postoperative subjective refraction smaller/ higher than or 0.75 D
- pregnancy (pregnancy test will be taken preoperatively in women of reproductive age)
Key Trial Info
Start Date :
January 3 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 3 2024
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT05194657
Start Date
January 3 2022
End Date
January 3 2024
Last Update
January 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital Vienna
Vienna, Austria, 1140